This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

MLV Announces Formation Of Advisory Board And Appointment Of Dr. Rahul Singhvi As Its Founding Director

Stocks in this article: NVAX

NEW YORK, June 3, 2011 /PRNewswire/ -- McNicoll, Lewis & Vlak LLC (MLV), a boutique investment bank focused on providing independent financial advice and unique capital markets expertise to corporate and institutional clients in capital intensive industries announced today the formation of an MLV Advisory Board comprised of industry leaders with expertise and experience in a range of businesses relevant to MLV's goal of providing unique and efficient capital raising and growth solutions for its clients.  At the same time, it announced the appointment of Dr. Rahul Singhvi, former President & CEO of Novavax, Inc. (Nasdaq: NVAX), a development stage vaccine company, as MLV Advisory Board's founding director.

(Logo: http://photos.prnewswire.com/prnh/20100920/NY67927LOGO )

In making the announcement, Patrice McNicoll, CEO of MLV noted, "MLV's mission is to create a new paradigm on Wall Street.  As a leader in At-the-Market (ATM) issuance, we are already delivering to clients the most efficient and cost-effective means of raising equity capital in the public markets.  We are creating our Advisory Board to bring together innovative business leaders to help us continue to develop new and unique growth and capital solutions for both public and private companies in capital intensive sectors."

"We are extremely pleased to have attracted someone of Dr. Singhvi's stature to spearhead our Advisory Board efforts," added Dean Colucci, President of MLV.  "Dr. Singhvi has been a visionary and a business leader in the vaccine and pharmaceutical industry.  During his tenure as CEO of Novavax, he transformed Novavax from a distressed specialty pharmaceutical Company into a premier vaccine development company.  Under his leadership, Novavax rapidly advanced a robust pipeline of technologically innovative and important clinical and preclinical stage vaccine candidates.  With Dr. Singhvi's assistance, MLV will seek to expand the MLV Advisory Board to include other executives with a similar track record of growth, success, and innovation."

Dr. Singhvi commented that, "I was drawn to MLV because of its ability to think outside of the box in advising public companies and in keeping their best interests in mind.   Patrice has assembled a diverse and creative team of professionals to build MLV.  I am delighted to have the opportunity to join them and work together to develop MLV's strategic direction and future product offerings."

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs